Latest News

Adults at high risk of melanoma recurrence and spread were able to stay cancer-free with personalized vaccines made with mRNA technology.

The Yale labs of Anna Marie Pyle and Craig Wilen have developed a norovirus vaccine, effective in mouse models, that portends a new approach to vaccine development for emerging RNA viruses.

Every time a cell divides, it shuts off its own transcription machinery. Researchers have discovered a surprising part of that process that may open a new door for cancer therapy.

A first-of-its-kind 3D genome atlas of human tonsil tissue leads to new discoveries in antibody production and beyond.

Amos Espinosa, a PhD candidate in the Krause Laboratory and a medical research scholar in the Yale Combined Program in the Biological and Biomedical Sciences, has been awarded an F31 NRSA Fellowship from the National Cancer Institute

Yale researchers present novel strategies for creating computer simulations and providing better emergency care, uncover new information about gut bacteria, and moderate a national discussion about science.

A team led by John Tsang, PhD, MMath, Anthony N. Brady Professor of Immunobiology, has been awarded a £4,200,000 grant from the Advanced Research + Invention Agency (ARIA) for a project that aims to decode and engineer coordinated immune responses that rapidly clear viruses in an effort to minimize viral spread and immunopathology.

Gut-homing antibodies provide powerful protection against norovirus, a new Yale study finds, revealing a potential new path for developing vaccines and therapies.

In a Q&A, Yale cancer scientist Luisa Escobar-Hoyos explains the challenges within pancreatic cancer treatment—and how patient outcomes can be improved.